Clinical guidance - DiabetesontheNet

Editorial: Lipid management, tirzepatide and hybrid closed-loop: What does new NICE guidance recommend?

With a raft of newly published NICE guidance, Jane Diggle discusses the implications for practice in primary care.

6 Mar 2024

Prescribing pearls: A guide to DPP-4 inhibitors (gliptins)

Understanding DPP-4 inhibitors: The essential information in one place.

6 Mar 2024

The 2024 ADA Standards of Care: What’s new?

Latest changes to the guidance: what primary and community care teams need to know.

6 Mar 2024

At a glance factsheet: Hybrid closed-loop therapy

What are HCL systems and what do we need to know about them in primary care?

6 Mar 2024

Latest news: Adult-onset type 1 diabetes; inequalities in diabetes care; and final HCL recommendations

Stay abreast of the latest news that could impact diabetes nursing.

2 Jan 2024

Journal club: New kids on the block – friend or foe?

New therapies show great potential, but at what cost?

27 Nov 2023

Final recommendations on hybrid closed-loop systems announced by NICE

Who will be offered HCL technology – and when.

14 Nov 2023

Final recommendations on hybrid closed-loop systems announced by NICE

NICE announces final appraisal recommendations on hybrid closed-loop systems for type 1 diabetes in England and Wales.

14 Nov 2023

At a glance factsheet: Newer lipid-lowering therapies in type 2 diabetes

The newer lipid-lowering therapies available, their different modes of action and their place in treatment.

7 Nov 2023

Diabetes Distilled: 2023 ESC guidelines on cardiovascular disease in patients with type 2 diabetes

Comprehensive guideline covers lifestyle, glycaemic targets, and blood pressure and lipid management.

7 Nov 2023

Latest news: Tirzepatide for type 2 diabetes; cardio-diabetes clinics; and cardiorenal biomarkers in DKD

Stay abreast of the latest news that could impact diabetes nursing.

31 Oct 2023

NICE recommends tirzepatide for type 2 diabetes

Revised draft guidelines set out new treatment option for type 2 diabetes.

18 Sep 2023

How to use SGLT2 inhibitors safely and effectively

Using sodium–glucose cotransporter 2 inhibitors safely, effectively and in line with the latest NICE guidance

18 Sep 2023

New proposal for hybrid closed-loop system rollout

NICE to consult over proposed adjustment to rollout.

22 Aug 2023

Making the most of SGLT2 inhibitors in primary care

Translating the cardiorenal benefits of SGLT2 inhibitors into practice.

3 Aug 2023

Editorial: Let’s not underestimate the impact of lifestyle on diabetes control

Amid shortages of diabetes drugs, Jane Diggle recommends new advice from PCDS and ABCD, but also reminds us of the benefits of lifestyle intervention.

20 Jul 2023

Joint PCDS and ABCD guidance: GLP-1 receptor agonist national shortage

Joint guidance from the PCDS and ABCD to support clinicians in selecting alternative glucose-lowering therapies when GLP-1 RAs are unavailable.

20 Jul 2023

At a glance factsheet: Peripheral arterial disease

Diagnosis and management of PAD: The essentials for primary care.

20 Jul 2023